Johnson And Johnson Company Profile

What is the competitive landscape for JOHNSON AND JOHNSON

JOHNSON AND JOHNSON has four approved drugs.

Summary for Johnson And Johnson

US Patents:	0
Tradenames:	4
Ingredients:	4
NDAs:	4

Drugs and US Patents for Johnson And Johnson

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-003	Dec 28, 1990		DISCN	No	No
Johnson And Johnson	MECLAN	meclocycline sulfosalicylate	CREAM;TOPICAL	050518-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-001	Dec 28, 1990		DISCN	No	No
Johnson And Johnson	ERYCETTE	erythromycin	SWAB;TOPICAL	050594-001	Feb 15, 1985		DISCN	Yes	No
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-002	Dec 28, 1990		DISCN	No	No
Johnson And Johnson	GRIFULVIN V	griseofulvin, microcrystalline	SUSPENSION;ORAL	050448-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No

Expired US Patents for Johnson And Johnson

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-001	Dec 28, 1990	RE30577
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-003	Dec 28, 1990	RE30577
Johnson And Johnson	VASCOR	bepridil hydrochloride	TABLET;ORAL	019002-002	Dec 28, 1990	RE30577

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Johns Hopkins Univ
• Johnson And Johnson
• Johnson Johnson Visn